<i>M</i>. <i>tuberculosis</i> ESX-3 periplasmic domain EccB3.

<i>M</i>. <i>tuberculosis</i> ESX-3 periplasmic domain EccB3.

<p>(a) EccB3 interactions with the five drugs having Z-scores values less than -1. (b) EccB3 dimer interface interaction with selamectin. (c) Molecular interactions between EccB3 interface residues and selamectin in 2D diagram. Ligplot was used for 2D map.</p>

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Ana Laura Granados-Tristán (21144439) (author)
مؤلفون آخرون: Mauricio Carrillo-Tripp (3183507) (author), Carlos Eduardo Hernández-Luna (21144442) (author), Aldo Herrera-Rodulfo (21144445) (author), Laura Adiene González-Escalante (8890166) (author), Ana Leticia Arriaga-Guerrero (8890154) (author), Beatriz Silva-Ramírez (8890169) (author), Brenda Leticia Escobedo-Guajardo (18809428) (author), Roberto Mercado-Hernández (8890172) (author), Mario Bermúdez de León (21144448) (author), Katia Peñuelas-Urquides (11639896) (author)
منشور في: 2025
الموضوعات:
Biophysics
Biochemistry
Medicine
Microbiology
Molecular Biology
Pharmacology
Biotechnology
Cancer
Infectious Diseases
Biological Sciences not elsewhere classified
Chemical Sciences not elsewhere classified
inhibited using crispri
3 secretion system
favorable δg values
tertiary protein structures
new therapeutic targets
eccd3 dimer interfaces
div >< p
mycolicibacterium smegmatis </
mycobacterium tuberculosis </
ivermectin susceptibility increased
mycobacterium susceptibility
smegmatis </
tuberculosis </
new drugs
molecular structures
ivermectin targets
eccd3 protein
eccd3 increased
best δg
resistant tuberculosis
vitro </
silico </
eccd3 </
zinc homeostasis
quaternary interface
prospective drugs
predicted based
preclinical studies
ivermectin action
compensatory mechanisms
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

مواد مشابهة